Inhibitors of Akt activity

Details for Australian Patent Application No. 2004233827 (hide)

Owner Merck & Co., Inc.

Inventors Wu, Zhicai; Bilodeau, Mark T.

Agent Spruson & Ferguson

Pub. Number AU-B-2004233827

PCT Pub. Number WO2004/096130

Priority 60/465,123 24.04.03 US

Filing date 20 April 2004

Wipo publication date 11 November 2004

Acceptance publication date 28 May 2009

International Classifications

C07D 471/16 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/44 (2006.01) - Non-condensed pyridines

C07D 471/14 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

3 November 2005 PCT application entered the National Phase

  PCT publication WO2004/096130 Priority application(s): WO2004/096130

28 May 2009 Application Accepted

  Published as AU-B-2004233827

24 September 2009 Standard Patent Sealed

21 January 2010 Amendment Made

  The nature of the amendment is: Amend the patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004233828-Inhibitors of Akt activity

2004233826-Inhibitors of Akt activity